SG Americas Securities’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,594
| Closed | -$39K | – | 2872 |
|
|
2025
Q1 | $39K | Sell |
3,594
-2,243
| -38% | -$24.3K | ﹤0.01% | 2898 |
|
|
2024
Q4 | $75K | Buy |
5,837
+2,959
| +103% | +$38K | ﹤0.01% | 2509 |
|
|
2024
Q3 | $79K | Buy |
2,878
+1,262
| +78% | +$34.6K | ﹤0.01% | 2788 |
|
|
2024
Q2 | $47K | Sell |
1,616
-1,797
| -53% | -$52.3K | ﹤0.01% | 2318 |
|
|
2024
Q1 | $152K | Sell |
3,413
-1,548
| -31% | -$68.9K | ﹤0.01% | 1951 |
|
|
2023
Q4 | $192K | Buy |
4,961
+2,234
| +82% | +$86.5K | ﹤0.01% | 1997 |
|
|
2023
Q3 | $80K | Buy |
+2,727
| New | +$80K | ﹤0.01% | 2575 |
|
|
2023
Q2 | – | Sell |
-3,398
| Closed | -$160K | – | 2440 |
|
|
2023
Q1 | $160K | Buy |
3,398
+324
| +11% | +$15.3K | ﹤0.01% | 2363 |
|
|
2022
Q4 | $213K | Buy |
3,074
+730
| +31% | +$50.6K | ﹤0.01% | 1941 |
|
|
2022
Q3 | $344K | Sell |
2,344
-2,032
| -46% | -$298K | ﹤0.01% | 1670 |
|
|
2022
Q2 | $571K | Buy |
4,376
+421
| +11% | +$54.9K | 0.01% | 1683 |
|
|
2022
Q1 | $399K | Buy |
+3,955
| New | +$399K | ﹤0.01% | 1805 |
|
|
2021
Q4 | – | Sell |
-531
| Closed | -$157K | – | 3187 |
|
|
2021
Q3 | $157K | Buy |
+531
| New | +$157K | ﹤0.01% | 3126 |
|